College ter Beoordeling van Geneesmiddelen — Tekorten (CBG-MEB)
College ter Beoordeling van Geneesmiddelen — Tekorten is the official source of medicine shortage information for Netherlands (EU). Mederti checks its register daily and links every notice back to the original publication.
- Official register
- www.cbg-meb.nl
- Country
- Netherlands
- Notices tracked by Mederti
- 2,700
- Last checked
- 16 Sept 2026
Latest notices from CBG-MEB
- Eplerenon — active, medium, since 15 Sept 2026 (source)
- Valproinezuur — active, medium, since 15 Sept 2026 (source)
- Atorvastatine — active, medium, since 15 Sept 2026 (source)
- Miconazol — active, medium, since 15 Sept 2026 (source)
- Foliumzuur — active, medium, since 15 Sept 2026 (source)
- Furosemide — active, medium, since 15 Sept 2026 (source)
- Finasteride — active, medium, since 15 Sept 2026 (source)
- Fexofenadine — active, medium, since 15 Sept 2026 (source)
- Zolmitriptan — active, medium, since 15 Sept 2026 (source)
- Diclofenac — active, medium, since 15 Sept 2026 (source)
- Doxorubicine — active, medium, since 15 Sept 2026 (source)
- Morfine — active, medium, since 15 Sept 2026 (source)
- Tolterodine — active, medium, since 15 Sept 2026 (source)
- Sertraline — active, medium, since 15 Sept 2026 (source)
- Clobazam — active, medium, since 15 Sept 2026 (source)
Every CBG-MEB notice, searchable and alertable
Search Netherlands's full register alongside 50+ other countries — free for individual pharmacists and clinicians.
Create a free accountMederti is not affiliated with or endorsed by College ter Beoordeling van Geneesmiddelen — Tekorten. All notices remain the property of their publisher and are linked to the original source.